Literature DB >> 12930047

Using hierarchical models to analyse clinical indicators: a comparison of the gamma-Poisson and beta-binomial models.

Peter P Howley1, Robert Gibberd.   

Abstract

BACKGROUND: Clinical indicators (CIs) are used to assess, compare and determine the potential to improve the care provided by hospitals and physicians. The results for Australian hospitals in 1998-2000 have been reported using a new methodology. The gamma-Poisson hierarchical model was used to correct for the effects of sampling variation by obtaining the empirical Bayesian shrunken estimates for the CI proportions for each hospital. Then, an estimate of the potential system gains that could be achieved if the mean proportion was shifted to the 20th centile is obtained for each of the 185 CIs. The results are sed to prioritize quality improvement activity.
OBJECTIVES: To describe the 20th centile method of calculating potential system gains in the health care system; to determine the impact of using the beta-binomial model rather than the gamma-Poisson model to obtain shrunken estimates for the CI proportions; and to compare the computationally simpler Method of Moments (MoM) with the maximum likelihood (ML) method for parameter estimation.
METHODS: The formulae for the gamma-Poisson and beta-binomial shrinkage estimators were compared analytically. Each of the shrinkage estimators and the two methods of parameter estimation were applied to the Obstetric and Gynecological CIs, and the results compared. RESULTS The comparison of the formulae for the two shrinkage estimators showed that the gamma-Poisson model results in: greater shrinkage towards the overall mean. This was verified empirically using the clinical indicators. Additionally, the MoM was not a viable alternative to the ML method.
CONCLUSIONS: The gamma-Poisson model provided smaller estimates of the potential system gains by up to 6.7% of the numerator for the clinical indicators. The difference in estimation increased with increasing mean proportions and between-hospital variation. We recommend that the beta-binomial model should be used on the basis of both theoretical and empirical grounds.

Entities:  

Mesh:

Year:  2003        PMID: 12930047     DOI: 10.1093/intqhc/mzg044

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  6 in total

Review 1.  Bayesian methods in reporting and managing Australian clinical indicators.

Authors:  Peter P Howley; Stephen J Hancock; Robert W Gibberd; Sheuwen Chuang; Frank A Tuyl
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

2.  Quality effects of operative delay on mortality in hip fracture treatment.

Authors:  R Sund; A Liski
Journal:  Qual Saf Health Care       Date:  2005-10

3.  Recognizing Differences in Hospital Quality Performance for Pediatric Inpatient Care.

Authors:  Jay G Berry; Alan M Zaslavsky; Sara L Toomey; Alyna T Chien; Jisun Jang; Maria C Bryant; David J Klein; William J Kaplan; Mark A Schuster
Journal:  Pediatrics       Date:  2015-07-13       Impact factor: 7.124

4.  Analysing low-risk patient populations allows better discrimination between high-performing and low-performing hospitals: a case study using inhospital mortality from acute myocardial infarction.

Authors:  Michael Coory; Ian Scott
Journal:  Qual Saf Health Care       Date:  2007-10

5.  Variation in the level of eGFR at dialysis initiation across dialysis facilities and geographic regions.

Authors:  Manish M Sood; Braden Manns; Allison Dart; Brett Hiebert; Joanne Kappel; Paul Komenda; Anita Molzahn; David Naimark; Sharon Nessim; Claudio Rigatto; Steven Soroka; Michael Zappitelli; Navdeep Tangri
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-23       Impact factor: 8.237

6.  Geographic and facility-level variation in the use of peritoneal dialysis in Canada: a cohort study.

Authors:  Manish M Sood; Navdeep Tangri; Brett Hiebert; Joanne Kappel; Allison Dart; Adeera Levin; Braden Manns; Anita Molzahn; David Naimark; Sharon J Nessim; Claudio Rigatto; Steven D Soroka; Michael Zappitelli; Paul Komenda
Journal:  CMAJ Open       Date:  2014-03-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.